Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1988-9-22
|
| pubmed:abstractText |
The initial experiences with metrizamide (Amipaque) in cases of spinal dysraphism are described. The technique, myelographic appearance and adverse reactions are discussed. The results have been promising and it is believed that this contrast medium will provide more accurate diagnostic information. However, further experience is necessary and in particular correlation with surgical findings.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
0365-5954
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
355
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
200-10
|
| pubmed:dateRevised |
2008-4-9
|
| pubmed:meshHeading |
pubmed-meshheading:400905-Adolescent,
pubmed-meshheading:400905-Child,
pubmed-meshheading:400905-Child, Preschool,
pubmed-meshheading:400905-Female,
pubmed-meshheading:400905-Humans,
pubmed-meshheading:400905-Infant,
pubmed-meshheading:400905-Male,
pubmed-meshheading:400905-Metrizamide,
pubmed-meshheading:400905-Myelography,
pubmed-meshheading:400905-Spinal Dysraphism
|
| pubmed:year |
1977
|
| pubmed:articleTitle |
Myelography with metrizamide in occult spinal dysraphism.
|
| pubmed:affiliation |
Department of Neuroradiology, Newcastle General Hospital, England.
|
| pubmed:publicationType |
Journal Article
|